CDC Website CDC Website

To Join the NPIN community or

You are here

Antiretroviral Drugs

COVID-19 Information |

For COVID-19 testing information please visit:

Directly contact organizations to find out about changes to services or hours.

Form Display: 

Funding Admin Form

Clinical and Behavioral Characteristics of Adults Receiving Medical Care for HIV Infection: Medical Monitoring Project 2005 Pilot Data Collection Cycle

NPIN admin's picture
This surveillance report presents results based on interview data from the pilot cycle of the Medical Monitoring Project (MMP), during which information was collected on patients in care during 2005. Data were collected during January 2006 - August 2007. Interviews were conducted in 10 project areas, and 899 persons participated; 72 percent were male, 26 percent female, and 2 percent transgender. Medical record abstractions were conducted in 6 project areas.

Drug Interactions

NPIN admin's picture
This information sheet uses a question and answer format to provide people who have HIV/AIDS with an overview of interactions between drugs used to treat HIV and other medications or drugs. It explains what drug interactions are, how the body processes drugs, how drugs interact, and what drugs cause the most interactions with HIV medications. In addition, the information sheet discusses the role of food in drug metabolism, drugs that require special attention, and interactions between herbal products and medications.

CDC Trials: Pre-Exposure Prophylaxis for HIV Prevention:Clinical Trials in Botswana, Thailand, and the United States

NPIN admin's picture

This information sheet discusses the clinical trials of the antiretroviral drug tenofovir disoproxil fumarate used alone or in combination with emtricitabine in Botswana, Thailand, and the United States. The trials in Botswana and Thailand are safety and efficacy trials, while the US trial is an extended safety trial. The trials are investigating the safety and efficacy of tenofovir as a daily oral prevention of HIV infection among three high risk populations: heterosexuals in Botswana, intravenous drug users in Thailand, and men who have sex with men in the US.

Speed Up Scale Up: Strategies, Tools and Policies to Get the Best HIV Treatment to More People, Sooner

NPIN admin's picture
This report outlines some of the strategies, tools and policies that have supported the scaling up of treatment during the past decade as well as those that can address persistent or new challenges. The results are presented from a 23-country survey of how consistently these strategies are being implemented. The findings demonstrate encouraging progress by some health ministries in adopting many of the enabling policies needed to facilitate scale-up and improve care. Nevertheless, the adoption and implementation of these strategies, tools and policies are lagging in some countries.

Adverse Events of Antiretroviral Drugs

NPIN admin's picture
This internet electronic file discusses side effects of antiretroviral therapy for persons with HIV. The file provides information in table form on the most common adverse events for each of the five types of antiretroviral drugs.

2012 HIV Sourcebook for the Primary Care Provider

NPIN admin's picture
This monograph is a sourcebook that provides information about HIV infection for professionals who work in today’s health care system. It is meant be a convenient reference for some of the most common issues encountered in daily practice. It contains an outline of basic HIV patient care, and a list of resources that can be accessed locally. It presents guidelines and recommendations related to antiretroviral therapy (ART), treatment of opportunistic diseases, HIV testing and counseling, prevention of perinatal transmission, and post-exposure prophylaxis.

What is Antiretroviral Therapy (ART)

NPIN admin's picture
This information sheet discusses antiretroviral therapy (ART), a treatment of HIV. It describes the HIV life cycle, lists the approved antiretroviral drugs and how each class of drugs works to block HIV and how the drugs are used. The information sheet also explains drug resistance, whether the drugs used for treatment can cure HIV or AIDS, when treatment should start, which of the drugs will be prescribed, and new research into HIV drugs.

Proven HIV Prevention Methods

NPIN admin's picture

There are more tools to effectively prevent HIV than ever before. Since no single strategy provides complete protection or is right for all individuals, a combination of methods is needed to help reduce HIV transmission. CDC and its partners are currently pursuing a High-Impact Prevention approach to reducing the continued toll of HIV. This approach seeks to use the best mix of proven, cost-effective, and scalable interventions for high-risk populations and areas of the nation (see "Future of HIV Prevention" fact sheet for information).


Subscribe to RSS - Antiretroviral Drugs